plerixafor has been researched along with Chronic Kidney Failure in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmadi, AR; Cameron, AM; Fu, Y; Gao, W; Hu, X; Montgomery, RA; Okabayashi, T; Raccusen, LC; Shigoka, M; Singer, AL; Sun, Z; Wang, Y; Wesson, RN; Williams, GM | 1 |
Cameron, AM; Hisada, M; Hu, X; Li, J; Montgomery, RA; Okabayashi, T; Raccusen, LC; Sun, Z; Wang, Y; Williams, GM; Zheng, Q | 1 |
Castelli, A; Conconi, A; Gaidano, G; Pinto, V | 1 |
Dunn, D; Jagasia, M; Savani, BN; Vikas, P | 1 |
1 review(s) available for plerixafor and Chronic Kidney Failure
Article | Year |
---|---|
Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease.
Topics: Amyloid; Amyloidosis; Anti-HIV Agents; Benzylamines; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Immunoglobulin Light Chains; Kidney Failure, Chronic; Lymphocytes; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation, Autologous | 2012 |
3 other study(ies) available for plerixafor and Chronic Kidney Failure
Article | Year |
---|---|
Chimeric Allografts Induced by Short-Term Treatment With Stem Cell Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: II, Study in Miniature Swine.
Topics: Allografts; Animals; Anti-HIV Agents; Benzylamines; Calcineurin Inhibitors; Cyclams; Graft Rejection; Graft Survival; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Kidney Failure, Chronic; Kidney Transplantation; Peripheral Blood Stem Cell Transplantation; Skin Transplantation; Swine; Swine, Miniature; Tacrolimus; Transplantation Chimera; Transplantation Tolerance | 2016 |
Chimeric Allografts Induced by Short-Term Treatment With Stem Cell-Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: A Study in Rats.
Topics: Allografts; Animals; Animals, Genetically Modified; Anti-HIV Agents; Benzylamines; Calcineurin Inhibitors; Cyclams; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Peripheral Blood Stem Cell Transplantation; Rats; Rats, Inbred Lew; Tacrolimus; Transplantation Chimera; Transplantation Tolerance | 2016 |
Safe and effective use of plerixafor plus G-CSF in dialysis-dependent renal failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Combined Modality Therapy; Cyclams; Dexamethasone; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Kidney Failure, Chronic; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Receptors, CXCR4; Renal Dialysis; Thalidomide; Transplantation Conditioning | 2010 |